Darbepoetin Alfa
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00012 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 12 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | amenorrhea (disease) | KG + DL |
| 2 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 3 | anaphylaxis | KG + DL |
| 4 | psoriasis | KG + DL |
| 5 | penile fibromatosis | KG + DL |
| 6 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 7 | Peyronie disease | KG + DL |
| 8 | Ledderhose disease | KG + DL |
| 9 | infantile digital fibromatosis | KG + DL |
| 10 | HER2 positive breast carcinoma | KG + DL |
| 11 | palmar fibromatosis | KG + DL |
| 12 | scalp dermatosis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.